Bridge Medicines
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
420 E 70th St, New York, New York, 10021...Phone Number
(646) 962-6852Website
www.bridgemedicines.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Bridge Medicines
Bridge Medicines is a pioneering drug-discovery company focused on advancing promising early technologies in major academic institutions from proof-of-concept to clinical development. The company was founded in 2016 and is headquartered in New York City.Explore more
Bridge Medicines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Bridge Medicines your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Bridge Medicines had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Bridge Medicines
Check if Bridge Medicines has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Bridge Medicines has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Bridge Medicines launches new products
Check out if Bridge Medicines is spiking on competitors!
Earning: See what the market has to say on Bridge Medicines recently announced quarterly report
Bridge Medicines, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Bridge Medicines
Find 2 more new buyers
Compare Similar Companies to Bridge Medicines
Compare insights from companies similar to Bridge Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Bridge Medicines is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Bridge Medicines is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Bridge Medicines.
Bridge Medicines financials insights
Gather financial insights about Bridge Medicines, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Unspecified
$10M
Bridge Medicines Tech Stack
A closer look at the technologies used by Bridge Medicines
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Award
Funding
Funding
Bridge Medicines News & Media
Bridge Medicines Announces Additional Funding of $10 Million from Inside Investors
NEW YORK, Nov. 12, 2020 /PRNewswire/ -- Bridge Medicines, a pioneering drug discovery company focused on advancing promising early technologies from concept to clinic, announced today the additional funding of $10 million to advance its current pipeline of products as well as expand with...Bridge Medicines Adds Small Molecule Inhibitors of Activated Factor XII to Pipeline
NEW YORK, Sept. 21, 2020 /PRNewswire/ -- Bridge Medicines and The Rockefeller University today announced an exclusive license agreement to further develop a series of small molecule inhibitors of activated Factor XII (FXIIa) discovered in the laboratory of Jan L. Breslow, M.D. Breslow and...Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
NEW YORK, March 11, 2019 /PRNewswire/ -- Bridge Medicines announced today an agreement with Weill Cornell Medicine to develop a novel sphingosine 1-phosphate (S1P) receptor modulator. This small molecule program originated in the laboratory of Timothy Hla, Ph.D. formerly of Weill Cornell...Bridge Medicines Accepts Novel Small Molecule Targeting Basal Cell Carcinoma As First Drug Candidate for Development
NEW YORK, March 14, 2018 /PRNewswire/ -- Bridge Medicines and the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) announced today the acceptance into Bridge Medicines of its first drug candidate, a small molecule for the treatment of basal cell carcinoma, that originated in...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Bridge Medicines
Sign Up For FreeTo access detailed company insights
Bridge Medicines is a pioneering drug-discovery company focused on advancing promising early technologies in major academic institutions from proof-of-concept to clinical development. The company was founded in 2016 and is headquartered in New York City.... Read More
